151 results
Page 3 of 8
8-K/A
EX-99.1
41e0qf46
22 Nov 23
Report of Independent Auditors
4:02pm
8-K/A
6ul6byi
22 Nov 23
Report of Independent Auditors
4:02pm
8-K
EX-99.1
hc2zhletk0
15 Nov 23
Regulation FD Disclosure
6:03am
S-8 POS
r2ptu 4hztj
2 Nov 23
Registration of securities for employees (post-effective amendment)
12:00am
S-8 POS
EX-23.1
wzif50 u7
2 Nov 23
Registration of securities for employees (post-effective amendment)
12:00am
S-8 POS
EX-23.2
gtwjldvy
2 Nov 23
Registration of securities for employees (post-effective amendment)
12:00am
8-K
lmfkg7tocfncxoz
4 Oct 23
Immunome and Morphimmune Announce Successful Completion of Merger with $125 Million PIPE to Develop Novel Targeted Cancer Therapies
6:56am
424B3
rhyd4 u7q3mgibtwd
28 Aug 23
Prospectus supplement
9:10am
S-4/A
vdeiq ugdtfqux9518jz
25 Aug 23
Registration of securities issued in business combination transactions (amended)
6:38am
S-4/A
EX-23.1
r84dlf 3h
25 Aug 23
Registration of securities issued in business combination transactions (amended)
6:38am
S-4/A
EX-23.2
9eay8x4 ll
25 Aug 23
Registration of securities issued in business combination transactions (amended)
6:38am
S-4/A
EX-23.3
0q7wzxkr4qv0l8
25 Aug 23
Registration of securities issued in business combination transactions (amended)
6:38am
S-4
EX-10.42
7kjkk
8 Aug 23
Registration of securities issued in business combination transactions
4:07pm
S-4
EX-10.43
u0dnxn8jrc8daev
8 Aug 23
Registration of securities issued in business combination transactions
4:07pm